Stay updated with breaking news from Seth Berkeley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW DELHI — India is struggling to export its surplus of Covid-19 vaccines as logistical hurdles delay their use in many countries despite low levels of inoculation, vaccine producer the Serum Institute of India (SII) and a government official said on Tuesday (Dec 14). The SII, the world's biggest vaccine maker that produces the AstraZeneca, Novavax and Sputnik Covid-19 shots,...
India is struggling to export its surplus of COVID-19 vaccines as logistical hurdles delay their use in many countries
India is struggling to export its surplus of Covid-19 vaccines as logistical hurdles delay their use in many countries despite low levels of inoculation, vaccine producer the Serum Institute of India (SII) and a government official said on Tuesday. The SII, the world's biggest vaccine maker that produces the AstraZeneca, Novavax and Sputnik Covid-19 shots, has already
India is struggling to export its surplus of Covid-19 vaccines as logistical hurdles delay their use in many countries despite low levels of inoculation, vaccine producer the Serum Institute of India (SII) and a government official said on Tuesday. The SII, the world's biggest vaccine maker that produces the AstraZeneca, Novavax and Sputnik Covid-19 shots, has already
NEW DELHI (Reuters) - India is struggling to export its surplus of COVID-19 vaccines as logistical hurdles delay their use in many countries despite low levels of inoculation, vaccine producer the Serum Institute of India (SII) and a government official said on Tuesday.